Login / Signup

Nanoliposomal Irinotecan With Fluorouracil and Leucovorin or Gemcitabine Plus Cisplatin in Advanced Cholangiocarcinoma: A Phase II Study of the AIO Hepatobiliary-YMO Cancer Groups (NIFE-AIO-YMO HEP-0315).

Thomas Jens EttrichDominik Paul ModestMarianne SinnJana K StrieflerBernhard OpitzThorsten GoetzeEike GallmeierStefan AngermeierLudwig Fischer von WeikersthalLutz JacobaschDirk WaldschmidtMichael NiedermeierMichael SohmAndreas W BergerGiulia ManziniUli FehrenbachTimo Alexander AuerClarissa HosseDaniel VogeleDisorn SookthaiMarina SchaafRainer MucheAxel HinkeThomas SeufferleinLukas Perkhofer
Published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Treatment of advanced CCA with nal-IRI/FU/LV demonstrated efficacy in first-line therapy without new safety findings and merits further validation.
Keyphrases
  • phase ii study
  • locally advanced
  • open label
  • papillary thyroid
  • rectal cancer
  • placebo controlled
  • mesenchymal stem cells
  • replacement therapy
  • cell therapy
  • bone marrow
  • childhood cancer
  • young adults
  • double blind